Rösener Thomas, Bienemann Olga, Sigl Kerstin, Schopp Nora, Schnitter Fabian, Flörke Ulrich, Hoffmann Alexander, Döring Artjom, Kuckling Dirk, Herres-Pawlis Sonja
Institut für Anorganische Chemie, RWTH Aachen University, Landoltweg 1, 52074, Aachen, Germany.
Technische Universität Dortmund, Fakultät CCB, Otto-Hahn-Str. 6, 44277, Dortmund, Germany.
Chemistry. 2016 Sep 12;22(38):13550-62. doi: 10.1002/chem.201602223. Epub 2016 Aug 9.
Copper complexes of the hybrid guanidine ligands 1,3-dimethyl-N-(quinolin-8-yl)-imidazolidin-2-imine (DMEGqu) and 1,1,3,3-tetramethyl-2-(quinolin-8-yl)-guanidine (TMGqu) have been studied comprehensively with regard to their structural and electrochemical properties and their activity in atom transfer radical polymerization (ATRP). A simple analysis of the molecular structures of the complexes gives no indication about their activity in ATRP; however, with the help of DFT and NBO analysis the influence of particular coordinating donors on the electrochemical properties could be fully elucidated. With an adequate DFT methodology and newly applied theoretical isodesmic reactions it was possible to predict the relative position of the redox potentials of copper complexes containing DMEGqu and TMGqu ligands. In addition, predictions could be made as to whether the complexes of DMEGqu or TMGqu are more active in ATRP. Four new Cu(I) complexes were tested in standard ATRP reactions and kinetically investigated both in bulk and in solution. It could be proven that complexes featuring DMEGqu possess a lower redox potential and are more active in ATRP, although the tetramethylguanidine moiety represents the stronger donor.
杂合胍配体1,3 - 二甲基 - N -(喹啉 - 8 - 基) - 咪唑烷 - 2 - 亚胺(DMEGqu)和1,1,3,3 - 四甲基 - 2 -(喹啉 - 8 - 基) - 胍(TMGqu)的铜配合物,已针对其结构和电化学性质以及它们在原子转移自由基聚合(ATRP)中的活性进行了全面研究。对这些配合物的分子结构进行简单分析,无法表明它们在ATRP中的活性;然而,借助密度泛函理论(DFT)和自然键轨道(NBO)分析,可以充分阐明特定配位供体对电化学性质的影响。采用适当的DFT方法和新应用的理论等键反应,可以预测含有DMEGqu和TMGqu配体的铜配合物氧化还原电位的相对位置。此外,还可以预测DMEGqu或TMGqu的配合物在ATRP中哪个更具活性。在标准ATRP反应中测试了四种新的Cu(I)配合物,并对其在本体和溶液中的动力学进行了研究。结果表明,具有DMEGqu的配合物具有较低的氧化还原电位,并且在ATRP中更具活性,尽管四甲基胍部分是更强的供体。